Publications by authors named "Joe Zhou"

Claim this Profile
A
Author Correction: Clonal evolution during metastatic spread in high-risk neuroblastoma.
Gunes Gundem, Max F Levine, Stephen S Roberts, Irene Y Cheung, Juan S Medina-Martínez, Joe Zhou

Nat Genet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications of artificial intelligence in current pharmacy practice: A scoping review.
Hatzimanolis Jessica, Riley Britney, El-Den Sarira, Aslani Parisa, Zhou Joe

Res Social Adm Pharm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution during metastatic spread in high-risk neuroblastoma.
Gunes Gundem, Max F Levine, Stephen S Roberts, Irene Y Cheung, Juan S Medina-Martínez, Joe Zhou

Nat Genet· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Gas Type, Oil, Salts and Detergent on Formation and Stability of Air and Carbon Dioxide Bubbles Produced by Using a Nanobubble Generator.
Kaiyu Zhou, Vincent Maugard, Wenming Zhang, Joe Zhou, Xuehua Zhang

Nanomaterials (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput glycolytic inhibitor discovery targeting glioblastoma by graphite dots-assisted LDI mass spectrometry.
Rui Shi, Peichen Pan, Rui Lv, Chongqing Ma, Enhui Wu, Joe Zhou

Sci Adv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological activity validation of a computationally designed Rituximab/CD3 T cell engager targeting CD20+ cancers with multiple mechanisms of action.
Wenyan Cai, Jianbo Dong, Sachith Gallolu Kankanamalage, Allison Titong, Jiadong Shi, Joe Zhou

Antib Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of novel neutralizing mouse monoclonal antibody JM1-24-3 developed against MUC18 in metastatic melanoma.
Runhua Feng, Yuling Wang, Vijaya Ramachandran, Qinhong Ma, Matthew M May, Joe X Zhou

J Exp Clin Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel anti-HER2 antibody GB235 reverses Trastuzumab resistance in HER2-expressing tumor cells in vitro and in vivo.
Mengjun Shu, Hongbin Yan, Chuanying Xu, Yan Wu, Zhaohua Chi, Qing Zhou, Joe X Zhou

Sci Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of JL1037 as a novel, specific, reversible lysine-specific demethylase 1 inhibitor that induce apoptosis and autophagy of AML cells.
Shuang Liu, Wenting Lu, Shouyun Li, Saisai Li, Jia Liu, Joe Zhongxiang Zhou

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trail Making Test Elucidates Neural Substrates of Specific Poststroke Executive Dysfunctions.
Ryan T Muir, Benjamin Lam, Kie Honjo, Robin D Harry, Alicia A McNeely, X Joe Zhou

Stroke· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability.
Vikas K Sharma, Thomas W Patapoff, Bruce Kabakoff, Satyan Pai, Eric Hilario, Joe Z Zhou

Proc Natl Acad Sci U S A· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probing antibody internal dynamics with fluorescence anisotropy and molecular dynamics simulations.
Ekaterine Kortkhonjia, Relly Brandman, Joe Zhongxiang Zhou, Vincent A Voelz, Ilya Chorny

MAbs· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biodistribution and pharmacokinetic evaluation of choline-bound gold nanoparticles in a human prostate tumor xenograft model.
Rene Razzak, Joe Zhou, XiaoHong Yang, Nadim Pervez, Eric Lr Bédard

Clin Invest Med· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pfizer Global Virtual Library (PGVL): a chemistry design tool powered by experimentally validated parallel synthesis information.
Qiyue Hu, Zhengwei Peng, Scott C Sutton, Jim Na, Jaroslav Kostrowicki, Joe Zhongxiang Zhou

ACS Comb Sci· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Process development for robust removal of aggregates using cation exchange chromatography in monoclonal antibody purification with implementation of quality by design.
Zhihao Xu, Jason Li, Joe X Zhou

Prep Biochem Biotechnol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.
Yi Wang, Tamara Noelle Hess, Victoria Jones, Joe Zhongxiang Zhou, Michael R McNeil

Bioorg Med Chem Lett· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An antibody targeted to VEGFR-2 Ig domains 4-7 inhibits VEGFR-2 activation and VEGFR-2-dependent angiogenesis without affecting ligand binding.
Jane Kendrew, Cath Eberlein, Brad Hedberg, Karen McDaid, Neil R Smith, Joe Zhou

Mol Cancer Ther· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide.
Luke Zehnder, Michael Bennett, Jerry Meng, Buwen Huang, Sacha Ninkovic, Joe Zhongxiang Zhou

J Med Chem· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoinformatics and library design.
Joe Zhongxiang Zhou

Methods Mol Biol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PGVL Hub: An integrated desktop tool for medicinal chemists to streamline design and synthesis of chemical libraries and singleton compounds.
Zhengwei Peng, Bo Yang, Sarathy Mattaparti, Thom Shulok, Thomas Thacher, Joe Zhongxiang Zhou

Methods Mol Biol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Zealand dental practitioners' experience of patient allergies to dental alloys used for prosthodontics.
Joe Zhou, Andrew Paul, Vincent Bennani, W Murray Thomson, Norman A Firth

N Z Dent J· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydroxyphenylisoindoline amides as orally bioavailable inhibitors of the heat shock protein 90 (hsp90) molecular chaperone.
Pei-Pei Kung, Buwen Huang, Gang Zhang, Joe Zhongxiang Zhou, Jeff Wang

J Med Chem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models.
Jeffrey L Brown, Z Alexander Cao, Maria Pinzon-Ortiz, Jane Kendrew, Corinne Reimer, Joe Q Zhou

Mol Cancer Ther· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial library-based design with Basis Products.
Joe Zhongxiang Zhou, Shenghua Shi, Jim Na, Zhengwei Peng, Tom Thacher

J Comput Aided Mol Des· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone.
Pei-Pei Kung, Lee Funk, Jerry Meng, Michael Collins, Joe Zhongxiang Zhou

Bioorg Med Chem Lett· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis